Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...

Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

Melanoma cells, the most aggressive form of skin cancer, produce a protein that blocks the recognition and removal of the ...

LUND, Sweden, March 26, 2025 /PRNewswire/ -- Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces the ...

The Mayo Clinic Center for Regenerative Biotherapeutics’ biomanufacturing capabilities help healthcare teams deliver next-generation treatments and cures for patients.

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Renowned centers like Immunity Therapy Center (ITC) in Tijuana provide patients with personalized programs that go beyond traditional methods.

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen ...

The warning comes amid reports that unregulated therapies are being offered directly to patients, potentially illegally.View ...

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...